X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare with Merck Ltd - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs MERCK LTD - Comparison Results

MERCK LTD 
   Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALKEM LABORATORIES MERCK LTD ALKEM LABORATORIES/
MERCK LTD
 
P/E (TTM) x - 50.9 - View Chart
P/BV x 7.1 7.7 92.3% View Chart
Dividend Yield % 0.6 0.4 166.0%  

Financials

 ALKEM LABORATORIES   MERCK LTD
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-16
MERCK LTD
Dec-16
ALKEM LABORATORIES/
MERCK LTD
5-Yr Chart
Click to enlarge
High Rs1,5891,060 149.9%   
Low Rs1,232623 197.8%   
Sales per share (Unadj.) Rs417.5632.4 66.0%  
Earnings per share (Unadj.) Rs56.345.7 123.1%  
Cash flow per share (Unadj.) Rs64.762.3 103.8%  
Dividends per share (Unadj.) Rs12.7011.00 115.5%  
Dividend yield (eoy) %0.91.3 68.9%  
Book value per share (Unadj.) Rs292.9388.8 75.3%  
Shares outstanding (eoy) m119.5716.60 720.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.41.3 253.9%   
Avg P/E ratio x25.118.4 136.1%  
P/CF ratio (eoy) x21.813.5 161.4%  
Price / Book Value ratio x4.82.2 222.5%  
Dividend payout %22.624.1 93.8%   
Avg Mkt Cap Rs m168,65313,969 1,207.3%   
No. of employees `000NA1.6 0.0%   
Total wages/salary Rs m9,1711,487 616.9%   
Avg. sales/employee Rs ThNM6,631.9-  
Avg. wages/employee Rs ThNM939.2-  
Avg. net profit/employee Rs ThNM479.4-  
INCOME DATA
Net Sales Rs m49,91510,498 475.5%  
Other income Rs m1,645242 678.7%   
Total revenues Rs m51,56110,741 480.0%   
Gross profit Rs m8,4821,135 747.1%  
Depreciation Rs m1,006276 365.1%   
Interest Rs m6710-   
Profit before tax Rs m8,4511,102 766.7%   
Minority Interest Rs m-1140-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,606343 467.8%   
Profit after tax Rs m6,731759 887.0%  
Gross profit margin %17.010.8 157.1%  
Effective tax rate %19.031.1 61.0%   
Net profit margin %13.57.2 186.5%  
BALANCE SHEET DATA
Current assets Rs m27,0626,410 422.2%   
Current liabilities Rs m15,3248,828 173.6%   
Net working cap to sales %23.5-23.0 -102.1%  
Current ratio x1.80.7 243.2%  
Inventory Days Days6758 115.3%  
Debtors Days Days4138 107.5%  
Net fixed assets Rs m12,6101,406 896.6%   
Share capital Rs m239166 144.0%   
"Free" reserves Rs m34,4906,286 548.7%   
Net worth Rs m35,0276,455 542.7%   
Long term debt Rs m1,2120-   
Total assets Rs m54,3878,828 616.0%  
Interest coverage x13.6NM-  
Debt to equity ratio x00-  
Sales to assets ratio x0.91.2 77.2%   
Return on assets %13.68.6 158.3%  
Return on equity %19.211.8 163.4%  
Return on capital %24.917.1 145.6%  
Exports to sales %12.98.3 156.3%   
Imports to sales %3.121.0 14.7%   
Exports (fob) Rs m6,461869 743.2%   
Imports (cif) Rs m1,5402,209 69.7%   
Fx inflow Rs m6,563959 684.5%   
Fx outflow Rs m3,0122,612 115.3%   
Net fx Rs m3,552-1,653 -214.8%   
CASH FLOW
From Operations Rs m7,2591,070 678.1%  
From Investments Rs m1,864-750 -248.7%  
From Financial Activity Rs m-9,273-150 6,190.1%  
Net Cashflow Rs m-150171 -87.8%  

Share Holding

Indian Promoters % 66.9 0.0 -  
Foreign collaborators % 0.0 51.8 -  
Indian inst/Mut Fund % 33.1 18.2 181.9%  
FIIs % 0.0 1.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 0.0 29.1 -  
Shareholders   68,381 28,591 239.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALKEM LABORATORIES With:   STRIDES SHASUN LTD  AJANTA PHARMA  UNICHEM LAB  DR. DATSONS LABS  CADILA HEALTHCARE  

Compare ALKEM LABORATORIES With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Slumps Over 275 Points; Realty and Banking Stocks Witness Selling(Closing)

After trading on a volatile note throughout the day, share markets in India witnessed selling pressure during the closing hours and ended the day in red.

Related Views on News

MERCK LTD Announces Quarterly Results (1QFY19); Net Profit Up 63.1% (Quarterly Result Update)

Aug 8, 2018 | Updated on Aug 8, 2018

For the quarter ended June 2018, MERCK LTD has posted a net profit of Rs 328 m (up 63.1% YoY). Sales on the other hand came in at Rs 2 bn (down 17.1% YoY). Read on for a complete analysis of MERCK LTD's quarterly results.

MERCK LTD Announces Quarterly Results (4QFY18); Net Profit Up 53.2% (Quarterly Result Update)

Jul 20, 2018 | Updated on Jul 20, 2018

For the quarter ended March 2018, MERCK LTD has posted a net profit of Rs 227 m (up 53.2% YoY). Sales on the other hand came in at Rs 3 bn (up 27.1% YoY). Read on for a complete analysis of MERCK LTD's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

Is It the Right Time to Buy Pharma Stocks Now?(The 5 Minute Wrapup)

Sep 12, 2018

Is the pharma sector poised for a comeback? Is the worst over? I believe so.

Want Bigger Returns Than You Thought Possible? This is Where You Should Look(Profit Hunter)

Sep 12, 2018

Richa has discovered the single most profitable opportunity in the market - read on to discover more...

Investors Are Redeeming From Equity Mutual Funds Now. Should You?(Outside View)

Sep 12, 2018

PersonalFN elucidates if you should redeem from equity mutual fund now, and the approach to follow before you decide to sell mutual funds.

Are You Blindly Investing In Equities? Read This...(Outside View)

Sep 11, 2018

PersonalFN explains how blindly investing in equities can prove hazardous to your wealth and health.

Outperformance of Strong Established Brands in the Indian Stock market(Chart Of The Day)

Sep 14, 2018

Strong Well established Indian Brands have comfortably outperformed the index in the decade post the global financial crisis.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALKEM LABORATORIES SHARE PRICE


Sep 21, 2018 (Close)

TRACK ALKEM LABORATORIES

  • Track your investment in ALKEM LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALKEM LABORATORIES

ALKEM LABORATORIES 8-QTR ANALYSIS

COMPARE ALKEM LABORATORIES WITH

MARKET STATS